Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples